| RS2501829507 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501830039 |
PNP
|
Health Risk |
Likely pathogenic |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS2501830093 |
PNP
|
Health Risk |
Conflicting classifications of pathogenicity |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS2501830680 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2501831752 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501832390 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501832537 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501832595 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501832728 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501833115 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501833361 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501833379 |
NALCN
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS2501834109 |
PNP
|
Health Risk |
Likely pathogenic |
— |
| RS2501835086 |
PNP
|
Health Risk |
Pathogenic |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS2501835633 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501835987 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501836317 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501836909 |
PNP
|
Health Risk |
Pathogenic |
Purine-nucleoside phosphorylase deficiency, Purine-nucleoside phosphorylase deficiency |
| RS2501838391 |
COL4A1
|
Health Risk |
Pathogenic |
— |
| RS2501840293 |
HNRNPC
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal dominant 74 |
| RS2501841517 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501841902 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501842149 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501842233 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501842561 |
SLC7A7
|
Health Risk |
Likely pathogenic |
SLC7A7-related disorder, Lysinuric protein intolerance |
| RS2501844173 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501844440 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501844566 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501845489 |
OXGR1
|
Health Risk |
Pathogenic |
Nephrolithiasis, calcium oxalate |
| RS2501847126 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501847136 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501849042 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2501851232 |
CEP290
|
Health Risk |
Pathogenic |
Meckel syndrome, type 4 |
| RS2501852178 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2501853049 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS2501854454 |
PIBF1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 33, PIBF1-related disorder |
| RS2501856727 |
FGF14
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 27, FGF14-related disorder |
| RS2501857420 |
CHD8
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2501857970 |
CHD8
|
Health Risk |
Likely pathogenic |
Rare genetic intellectual disability, Rare genetic intellectual disability |
| RS2501858298 |
FGF14
|
Health Risk |
Pathogenic |
— |
| RS2501858533 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS2501859189 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS2501859414 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2501860074 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501860374 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501862857 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2501862875 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2501863310 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2501863593 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501863948 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501864551 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501866353 |
NALCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractures of the limbs and face, hypotonia |
| RS2501867057 |
CHD8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2501886630 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS2501888861 |
CHD8
|
Health Risk |
Pathogenic |
CHD8-related disorder, CHD8-related disorder |
| RS2501893676 |
ZMYM2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities |
| RS2501896369 |
ZMYM2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2501896375 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2501896438 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501896457 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501897755 |
ZMYM2
|
Health Risk |
Pathogenic |
ZMYM2-related disorder, ZMYM2-related disorder |
| RS2501897802 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501900617 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2501900788 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501901102 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501903108 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2501904395 |
ZMYM2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2501908160 |
ZMYM2
|
Health Risk |
Pathogenic |
— |
| RS2501911040 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2501913432 |
CHD8
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2501923179 |
CHD8
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2501923833 |
CHD8
|
Health Risk |
Pathogenic |
— |
| RS2501925066 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501930345 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS2501931660 |
FGF14
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 27A, Spinocerebellar ataxia 27A |
| RS2501931899 |
FGF14
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 27A, Spinocerebellar ataxia 27A |
| RS2501941944 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501947501 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501947601 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501948490 |
TGDS
|
Health Risk |
Likely pathogenic |
— |
| RS2501953922 |
CHD8
|
Health Risk |
Likely pathogenic |
— |
| RS2501954565 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS2501965282 |
TMTC3
|
Health Risk |
Likely pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS2501974171 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501974273 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501974931 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501975297 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501975599 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501975686 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501975835 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501976400 |
NALCN
|
Health Risk |
Pathogenic |
— |
| RS2501976760 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501977003 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501977331 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501977415 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501977529 |
SLC7A7
|
Health Risk |
Pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501977684 |
SLC7A7
|
Health Risk |
Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501977813 |
SLC7A7
|
Health Risk |
Pathogenic/Likely pathogenic |
Lysinuric protein intolerance, Lysinuric protein intolerance |
| RS2501978087 |
TMTC3
|
Health Risk |
Likely pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS2501978213 |
TMTC3
|
Health Risk |
Pathogenic |
— |